Navigation Links
PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
Date:1/15/2014

hat Induces Disease Remission 576.2.6 Improved Quality of Life for Both Patients and their Carers 586.3 Unmet Needs Gap Analysis 586.4 Opportunities 606.4.1 Increase Treatment Armamentarium for Severe Recalcitrant Patients 606.4.2 Predictive Tests for Patient Stratification 606.4.3 More Therapeutic Options that Address Patients' Pruritus 617 Pipeline Assessment 627.1 Overview 627.2 Promising Drugs in Clinical Development 647.2.1 Phase II Pipeline Products 668 Market Outlook 678.1 Global Drivers and Barriers 678.1.1 Driver: Anticipated launch of the first biologic for the treatment of moderate to severe disease 678.1.2 Driver: The underserved severe refractory patient segment presents an untapped market opportunity 688.1.3 Driver: A drug that is able to target two or more atopic diseases would gain a foothold in these markets 688.1.4 Driver: Atopic dermatitis presents an attractive patient population for drug developers 688.1.5 Driver: Restoring skin barrier function remains a key goal of disease management, meaning a continued need for moisturizers and topical agents 698.1.6 Barrier: First to second line of therapy is dominated by cheap, genericized topical drugs which create significant obstacles for novel drugs hoping to penetrate the market 708.1.7 Barrier: The largest atopic dermatitis patient segment - mild disease - can be well-controlled on most forms of topical therapy 708.1.8 Barrier: Pediatric sufferers are the largest patient group and pose a high bar in terms of safety for new products 708.1.9 Barrier: The complexity of the multiple etiologies that lead to atopic dermatitis means that treatment outcomes with existing drugs are not universal across all patient groups 718.1.10 Barrier: A significant proportion of patients experience disease remission in their early adolescent years and this may occur without drug therapy 728.2 India 738.2.1 Forecast 738.2.2 Key Events 758.2.3 Drivers and Barriers 769 Appendix 789.1 Bibliography 78
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
10. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
11. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Mass., May 19, 2011 Alere Inc. (NYSE: ALR ... their health at home through the merger of rapid diagnostics and ... its Series B Convertible Perpetual Preferred Stock (NYSE: ALR ... Series B stock in an amount per share equal to the ...
... a segment of BD (Becton, Dickinson and Company) (NYSE: ... BD MAX™ for use as an open system. ... molecular system designed to perform a broad range of molecular ... but also user-defined protocols and life science research applications. The ...
Cached Medicine Technology:BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases 2BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases 3
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader in ... the release and publication of their newest offering to complement the existing line ... , Designed in support of coverage for the full spectrum of Semi ...
(Date:7/1/2015)... ... ... A June 19th article by the Associated Press discussed a recent announcement by ... of medical care, specifically for seniors. Medicare recently completed the first year of a three ... Medicare’s chief medical officer, Dr. Patrick Conway said that “If we can keep people as ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar ... develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from the National ...
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in ... histones, remain constant in the brain, never changing after development in the womb. Now, ... are steadily replaced in brain cells throughout life – a process which helps to ...
(Date:7/1/2015)... Allen, TX (PRWEB) , ... July 01, 2015 ... ... designed for retail, long term care, specialty, combo, and compounding pharmacy operations, announces ... upcoming attendance to the Cardinal Health RBC event at the Venetian ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 2Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... 28 Shazaaam! LLC, an integrated,marketing communications ... Public Relations and Marketing Communications Agency of,Record ... will provide social marketing, proactive and reactive,blogging, ... enhance,ETC,s branding and visibility among its target ...
... study from Rice University chemists and scientists in the ... based on carbon nanotubes can help prevent people from ... new study was commissioned after preliminary tests found the ... reducing the effects of acute radiation injury than the ...
... Senior Writer Daniel Gross looks at,the signs that are ... not,that will pull the rest of world down with ... economic activity lasting more than a few months,and because ... declared until long after they start. In short, the ...
... of researchers in Australia, the United Kingdom and the ... from the mother to the next generation in a ... in Nature Genetics*, shows for the first time how ... failure and epilepsy are passed from mother to offspring. ...
... rhinitis, conjunctivitis or insect bites , , SATURDAY, Jan. ... asthma, rhinitis, conjunctivitis or stinging insect allergies, you ... also known as immunotherapy. , That,s the recommendation ... Immunology. , "Immunotherapy is a form of treatment ...
... Society of Plastic Surgeons (ASPS) today addressed concerns,regarding ... events following,a recent petition from a consumer group., ... U.S. Food and Drug,Administration (FDA) implement labeling changes ... one million people have been treated with BOTOX ...
Cached Medicine News:Health News:Shazaaam! Named PR Agency of Record for Enuresis Treatment Center 2Health News:Feds fund study of drug that may prevent radiation injury 2Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 2Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 3Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 4Health News:NEWSWEEK: Media Lead Sheet/February 4, 2008 Issue (on newsstands Monday, January 28) 5Health News:In silico modeling helps predict severity of mitochondrial disease 2Health News:Allergy Shots Are Effective Treatment for Symptoms 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... RoamAlert Integrity system builds on the ... door controllers in the system are ... a standard Windows® operating system, which ... of a personal computer, RoamAlert Integrity ...
... Radianse indoor positioning solution ... of where and when ... flow through care processes. ... provides intelligence that hospitals ...
Medicine Products: